Ropinirole - Antares Pharma/Jazz Pharmaceuticals
Alternative Names: AP-1126; JZP-7; Ropinirole ATD™ Gel; Ropinirole transdermal gelLatest Information Update: 26 May 2022
Price :
$50 *
At a glance
- Originator Antares Pharma
- Developer Jazz Pharmaceuticals
- Class Amines; Antiparkinsonians; Indoles; Sleep disorder therapies; Small molecules
- Mechanism of Action Dopamine D2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Restless legs syndrome
Most Recent Events
- 24 May 2022 Antares Pharma has been acquired by Halozyme Therapeutics
- 10 Aug 2010 Discontinued - Phase-I for Restless legs syndrome in USA (Transdermal)
- 15 Apr 2008 Jazz Pharmaceuticals completes a second phase I, pharmacokinetic trial for Restless legs syndrome in USA